We are live on ! Find out more
IDYA icon

IDEAYA Biosciences

82 hedge funds and large institutions have $284M invested in IDEAYA Biosciences in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 9

131% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 13

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

21% more funds holding

Funds holding: 6882 (+14)

20% more capital invested

Capital invested by funds: $236M → $284M (+$48M)

4.96% more ownership

Funds ownership: 66.59%71.55% (+5%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $155K

Holders
82
Holders Change
+14
Holders Change %
+20.59%
% of All Funds
1.45%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
23
Increased
30
Reduced
13
Closed
9
Calls
Puts
$155K
Net Calls
-$155K
Net Calls Change
-$155K
Name Holding Trade Value Shares
Change
Change in
Stake
MCCP
26
Mission Creek Capital Partners
California
$805K +$779K +57,532 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$678K +$98K +7,235 +18%
SCM
28
Sio Capital Management
New York
$676K -$90.8K -6,702 -12%
HLA
29
Hamilton Lane Advisors
Pennsylvania
$640K +$619K +45,692 New
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$573K +$174K +12,816 +45%
Charles Schwab
31
Charles Schwab
California
$549K
AQR Capital Management
32
AQR Capital Management
Connecticut
$545K +$528K +38,959 New
Ensign Peak Advisors
33
Ensign Peak Advisors
Utah
$517K
Wells Fargo
34
Wells Fargo
California
$517K +$324K +23,909 +183%
JAMONY
35
Jacob Asset Management of New York
California
$504K +$488K +36,000 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$497K +$32.4K +2,390 +7%
Squarepoint
37
Squarepoint
New York
$433K -$480K -35,405 -53%
Goldman Sachs
38
Goldman Sachs
New York
$411K +$258K +19,060 +185%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$409K +$396K +29,197 New
Citadel Advisors
40
Citadel Advisors
Florida
$397K +$384K +28,336 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$337K
TD Asset Management
42
TD Asset Management
Ontario, Canada
$329K +$318K +23,500 New
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$309K +$36.6K +2,700 +14%
AllianceBernstein
44
AllianceBernstein
Tennessee
$272K
AC
45
Athanor Capital
New York
$260K +$3.43K +253 +1%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$245K +$52.1K +3,849 +28%
Ameriprise
47
Ameriprise
Minnesota
$213K +$1.49K +110 +0.7%
GA
48
Greenspring Associates
Maryland
$213K +$206K +15,234 New
Aberdeen Group
49
Aberdeen Group
United Kingdom
$201K +$180K +13,320 New
AA
50
AlphaCentric Advisors
Puerto Rico
$175K +$149K +11,000 +733%

IDYA Hedge Fund Activity: Q4 2020 in Review

82 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q4 2020, worth a combined $284M — up 20% from $236M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new IDYA positions and 9 closed out — a net gain of 14 holders — while 30 added to existing stakes and 13 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $25M. The largest seller was 5AM Venture Management, cutting an estimated $22.6M.

  • 82 institutional investors held IDEAYA Biosciences (IDYA) as of Q4 2020, up from 68 in Q3 2020.
  • Funds reported $284M of IDEAYA Biosciences stock for Q4 2020, up 20% quarter-over-quarter.
  • 23 funds opened new IDEAYA Biosciences positions in Q4 2020 and 9 closed out, a net change of +14 holders.
  • The largest IDEAYA Biosciences buyer in Q4 2020 was RTW Investments, an estimated $25M added.
  • The largest IDEAYA Biosciences seller in Q4 2020 was 5AM Venture Management, an estimated $22.6M sold.

Based on aggregated 13F filings for Q4 2020.